Back
Iterum Therapeutics PLC Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
69
ITRM
Iterum Therapeutics PLC
Last Price:
1.35
Seasonality Move:
36.73%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bullish and ITRM is experiencing selling pressure, which indicates risk of future bearish movement.
Iterum Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.35 | Buy |
| 20-day SMA: | 1.3 | Buy |
| 50-day SMA: | 1.14 | Buy |
| 200-day SMA: | 1.33 | Buy |
| 8-day EMA: | 1.37 | Buy |
| 20-day EMA: | 1.29 | Buy |
| 50-day EMA: | 1.21 | Buy |
| 200-day EMA: | 1.28 | Buy |
Iterum Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 56.41 | Buy |
| Chaikin Money Flow: | -1223957 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.45) | Buy |
| Bollinger Bands (100): | (1.03 - 1.35) | Buy |
Iterum Therapeutics PLC Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Iterum Therapeutics PLC Stock
Is Iterum Therapeutics PLC Stock a Buy?
- Iterum Therapeutics PLC share price is 1.42 while ITRM 8-day simple moving average is 1.35, which is a Buy signal.
- The stock price of ITRM is 1.42 while Iterum Therapeutics PLC 20-day SMA is 1.30, which makes it a Buy.
- Iterum Therapeutics PLC 50-day simple moving average is 1.14 while ITRM share price is 1.42, making it a Buy technically.
- ITRM stock price is 1.42 and Iterum Therapeutics PLC 200-day simple moving average is 1.33, creating a Buy signal.
ITRM Technical Analysis vs Fundamental Analysis
Buy
69
Iterum Therapeutics PLC (ITRM)
is a Buy
Is Iterum Therapeutics PLC a Buy or a Sell?
-
Iterum Therapeutics PLC stock is rated a Buy
The current Iterum Therapeutics PLC [ITRM] share price is $1.42. The Score for ITRM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Iterum Therapeutics PLC Stock Info
Market Cap:
23.43M
Price in USD:
1.42
Share Volume:
1.29M
Iterum Therapeutics PLC 52-Week Range
52-Week High:
2.50
52-Week Low:
0.71
Buy
69
Iterum Therapeutics PLC (ITRM)
is a Buy
Iterum Therapeutics PLC Share Price Forecast
-
What is the Iterum Therapeutics PLC stock price today?
The Iterum Therapeutics PLC stock price is 1.42 USD today. -
Will ITRM stock go up or go down?
Iterum Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Iterum Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Iterum Therapeutics PLC is not overvalued.
Is Iterum Therapeutics PLC Stock a Buy?
- Iterum Therapeutics PLC share price is 1.42 while ITRM 8-day exponential moving average is 1.37, which is a Buy signal.
- The stock price of ITRM is 1.42 while Iterum Therapeutics PLC 20-day EMA is 1.29, which makes it a Buy.
- Iterum Therapeutics PLC 50-day exponential moving average is 1.21 while ITRM share price is 1.42, making it a Buy technically.
- ITRM stock price is 1.42 and Iterum Therapeutics PLC 200-day simple moving average is 1.28, creating a Buy signal.
Fundamental Analysis of Iterum Therapeutics PLC
Is Iterum Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.53 per share, and an increase next year of $0.21 per share.
Technical Analysis of Iterum Therapeutics PLC
Should I short Iterum Therapeutics PLC stock?
- ITRM Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Iterum Therapeutics PLC is a Buy
- Iterum Therapeutics PLC Relative Strength Index (RSI) is 56.41, which suggest Iterum Therapeutics PLC is overbought
- The Bollinger Bands (25) for Iterum Therapeutics PLC is (1.01 - 1.45), which suggest Iterum Therapeutics PLC is a Buy
- The Bollinger Bands (100) for Iterum Therapeutics PLC is (1.03 - 1.35), which suggest Iterum Therapeutics PLC is a Buy
* Iterum Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.